Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities
- 15 February 2012
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 83 (4), 543-550
- https://doi.org/10.1016/j.bcp.2011.11.004
Abstract
No abstract availableFunding Information
- NIH (DA10714, DA010714-13S1)
- Career Development Award from the Minneapolis Medical Research Foundation (MP)
This publication has 30 references indexed in Scilit:
- A Vaccine Strategy that Induces Protective Immunity against HeroinJournal of Medicinal Chemistry, 2011
- Synthesis of Mercapto-(+)-methamphetamine Haptens and Their Use for Obtaining Improved Epitope Density on (+)-Methamphetamine Conjugate VaccinesJournal of Medicinal Chemistry, 2011
- Impact of Distinct Chemical Structures for the Development of a Methamphetamine VaccineJournal of the American Chemical Society, 2011
- Anti-cocaine vaccine developmentExpert Review of Vaccines, 2010
- Nicotine hapten structure, antibody selectivity and effect relationships: Results from a nicotine vaccine screening procedureVaccine, 2010
- The Synthesis of Haptens and Their Use for the Development of Monoclonal Antibodies for Treating Methamphetamine AbuseJournal of Medicinal Chemistry, 2009
- Cocaine Vaccine for the Treatment of Cocaine Dependence in Methadone-Maintained PatientsArchives of General Psychiatry, 2009
- Enhanced immunogenicity of a bivalent nicotine vaccineInternational Immunopharmacology, 2008
- Using Hapten Design to Discover Therapeutic Monoclonal Antibodies for Treating Methamphetamine AbuseThe Journal of pharmacology and experimental therapeutics, 2007
- Epitope mapping using combinatorial phage-display libraries: a graph-based algorithmNucleic Acids Research, 2006